Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer—results of a first-in-man dose-escalation study with a fixed-dose extension phase
Titel:
Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer—results of a first-in-man dose-escalation study with a fixed-dose extension phase
Auteur:
Isambert, N. Delord, J.-P. Soria, J.-C. Hollebecque, A. Gomez-Roca, C. Purcea, D. Rouits, E. Belli, R. Fumoleau, P.